SynthesisThe Cochrane database of systematic reviews2022

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

George A Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.